Dapagliflozin: 'Helpful Strategy' for T1D?

Research presented at EASD 2017 shows that dapagliflozin may reduce insulin requirements with a low risk of adverse effects in patients with type 1 diabetes.

Source: Medscape Diabetes & Endocrinology Podcast - October 20, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts